507
Participants
Start Date
November 28, 2018
Primary Completion Date
October 25, 2022
Study Completion Date
March 31, 2026
zolbetuximab
Zolbetuximab were administered as a minimum 2-hour IV infusion.
oxaliplatin
Oxaliplatin were administered as a 2-hour IV infusion.
capecitabine
Capecitabine were administered orally twice daily (bid).
placebo
Placebo were administered as a minimum 2-hour IV infusion.
Weill Cornell Medical College (WCMC), New York
Montefiore Medical Center (MMC), The Bronx
Prisma Health Cancer Institute, Boiling Springs
University of Kansas Cancer Center and Medical Pavilion, Fairway
Ochsner Clinic CCOP, New Orleans
Parkland Hospital, Dallas
University of Texas Southwestern Medical Center, Dallas
Houston Methodist Cancer Center and Institute of Academic Medicine - Oncology, Houston
Utah Cancer Specialist, Salt Lake City
New Mexico Oncology Hematology, Albuquerque
Pacific Cancer Care, Monterey
Site AR54009, Buenos Aires
Site GB44005, Northwood
Site AR54006, Pergamino
Site AR54001, San Miguel de Tucumán
Site AR54004, San Miguel de Tucumán
Site AR54003, Viedma
Site CA15003, Chicoutimi
Site CA15002, Rimouski
Site CA15004, Calgary
Site CN86034, Fuzhou
Site CN86037, Fuzhou
Site CN86032, Haikou
Site CN86012, Zhengzhou
Site CN86029, Changsha
Site CN86043, Hengyang
Site CN86027, Suzhou
Site CN86046, Wuxi
Site CN86007, Hangzhou
Site CN86044, Baoding
Site CN86035, Beijing
Site CN86050, Beijing
Site CN86025, Bengbu
Site CN86002, Changchun
Site CN86049, Changchun
Site CN86053, Changchun
Site CN86021, Changzhou
Site CN86039, Chengdu
Site CN86052, Dalian
Site CN86054, Dalian
Site CN86015, Fuzhou
Site CN86001, Guangzhou
Site CN86042, Guangzhou
Site CN86051, Haebrin
Site CN86036, Hangzhou
Site CN86038, Linyi
Site CN86016, Nanjing
Site CN86045, Nanning
Site CN86014, Shanghai
Site CN86026, Shantou
Site CN86047, Shenyang
Site CN86017, Shijiazhuang
Site CN86009, Tianjin
Site CN86040, Tianjin
Site CN86031, Ürümqi
Site CN86004, Wuhan
Site CN86005, Wuhan
Site CN86013, Xi'an
Site CN86030, Xiamen
Site CN86011, Xuzhou
Site CN86024, Zhengzhou
Site HR38501, Varaždin
Site HR38502, Zagreb
Site HR38503, Zagreb
Site GR30001, Athens
Site GR30004, Heraklion
Site GR30003, Larissa
Site GR30005, Neo Faliro, Piraeus
Site GR30007, Rio Patras
Site GR30002, Thessaloniki
Site GR3006, Thessaloniki
Site IE35301, Dublin
Site IE35302, Dublin
Site JP81007, Fukuoka
Site JP81008, Akashi
Site JP81003, Kawasaki
Site JP81001, Yokohama
Site JP81010, Suita
Site JP81005, Utsunomiya
Site JP81002, Chiba
Site JP81006, Kashiwa
Site JP81004, Kita-gun
Site JP81012, Kōtoku
Site JP81009, Matsuyama
Site JP81011, Tsukiji
Site MY60001, George Town
Site MY60004, Kota Kinabalu
Site MY60002, Kuala Lumpur
Site MY60003, Kuala Lumpur
Site MY60005, Kuala Lumpur
Site NL31004, Groningen
Site NL31003, Tilburg
Site PT35109, Braga
Site PT35110, Coimbra
Site PT35111, Guimarães
Site PT35102, Lisbon
Site PT35106, Lisbon
Site PT35105, Porto
Site PT35108, Porto
Site PT35104, Santa Maria da Feira
Site PT35101, Setúbal
Site PT35107, Vila Real
Site RO40002, Bucharest
Site RO40005, Cluj-Napoca
Site RO40007, Cluj-Napoca
Site RO40003, Craiova
Site RO40004, Floreşti
Site RO40001, Iași
Site RO40006, Iași
Site RO40008, Timișoara
Site KR82002, Daegu
Site KR82006, Goyang-si
Site KR82007, Gyeonggi-do
Site KR82014, Incheon
Site KR82008, Jeollanam-do
Site KR82010, Jeonju
Site KR82011, Seongnam-si
Site KR82001, Seoul
Site KR82003, Seoul
Site KR82012, Seoul
Site KR82013, Seoul
Site KR82015, Seoul
Site KR82009, Suwon
Site ES34005, A Coruña
Site ES34006, Barcelona
Site ES34009, Barcelona
Site ES34010, Barcelona
Site ES34001, Elche
Site ES34002, Madrid
Site ES34003, Madrid
Site ES34008, Madrid
Site ES34013, Madrid
Site ES34011, Málaga
Site ES34004, Pamplona
Site ES34007, Valencia
Site ES34012, Valencia
Site TW88602, Kaohsiung City
Site TW88603, Taichung
Site TW88604, Taipei
Site TW88605, Tianan
Site TH66002, Bangkok
Site TH66005, Bangkok
Site TH66007, Bangkok
Site TH66009, Bangkok
Site TH66011, Laksi
Site TH66001, Muang
Site TH66003, Muang
Site TH66006, Pathum Thani
Site TH66010, Pathumwan
Site TH66004, Songkhla
Site TH66008, Vadhana
Site TR90008, Pendik
Site TR90003, Atakum
Site TR90004, Balcalı
Site TR90012, Bornova
Site TR90001, Bursa
Site TR90002, Istanbul
Site TR90010, Istanbul
Site TR90015, Istanbul
Site TR90007, Konya
Site TR90013, Konyaalti
Site TR90011, Malatya
Site GB44002, Bristol
Site GB44004, Cardiff
Site GB44001, London
Astellas Pharma Global Development, Inc.
INDUSTRY